Quidelortho Corp (QDEL) Stock Price, Quote & News

Company Profile

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, ant...

Industry: Medical Devices

Sector: Healthcare

Phone: 858 552 1100

Fax: 858 453 4338

Website: www.quidelortho.com

Address:

9975 Summers Ridge Road, San Diego, United States

Money_Stream_6524 Dec. 12 at 5:14 PM

$QDEL Mainz Biomed is doing the boring work I respect, shifting away from expensive DTC and leaning into lab partners, and they reported lab partner sales up about $60K or ~30% over 6 months

0 · Reply

Staska Dec. 12 at 2:46 PM

$QDEL Frontier Capital increased its stake in QuidelOrtho by 37.6% to 738,716 shares (about 1.09% of the company) valued at $21.29 million, while other institutions like State Street also meaningfully boosted positions and institutional ownership stands near 99%. Insider buying accelerated: CFO Joseph Busky bought 4,770 shares and CEO Brian Blaser bought 23,500 shares, raising their holdings by 221.9% and 389.5% respectively, with insiders acquiring 29,390 shares (~$657K) in the past 90 days. QuidelOrtho topped quarterly estimates (EPS $0.80 vs. $0.51 expected; revenue $699.9M vs. $667.5M) and set FY2025 guidance of 2.00–2.15 EPS, https://www.marketbeat.com/instant-alerts/filing-frontier-capital-management-co-llc-has-2129-million-stock-holdings-in-quidelortho-corporation-qdel-2025-12-12/

0 · Reply

landonmorris13 Dec. 11 at 8:00 PM

$QDEL Mainz Biomed tape is so thin that a 20–30k order can reclaim VWAP around 1.07–1.08 and tag 1.10 in minutes, once 1.12 breaks I’m eyeing that 1.15–1.20 shelf as the next liquidity magnet

0 · Reply

goinbananas Dec. 11 at 6:58 PM

$QDEL I’ll take a nice 30% gain in 5 weeks any time 👍 lot more coming! $ARKG $LABU $QQQ

0 · Reply

Staska Dec. 11 at 6:45 PM

$QDEL As of November 28, 2025, QuidelOrtho (QDEL) had a short interest of 11.48 million shares sold short, representing 17.03% of the public float. This marks a 3.80% increase in short interest since the prior report. The short interest ratio (days to cover) is 9.0, meaning it would take 9.0 days of the average trading volume of 1.33 million shares to cover all short positions. https://www.marketbeat.com/stocks/NASDAQ/QDEL/short-interest/?utm_source=chatgpt.com

0 · Reply

Staska Dec. 11 at 5:20 PM

$QDEL https://www.marketbeat.com/instant-alerts/filing-norges-bank-invests-927-million-in-quidelortho-corporation-qdel-2025-12-10/

0 · Reply

AdamInvest Dec. 10 at 7:54 AM

$QDEL down down

0 · Reply

Estimize Dec. 3 at 1:09 PM

Wall St is expecting 0.42 EPS for $QDEL Q4 [Reporting 02/18 AMC] http://www.estimize.com/intro/qdel?chart=historical&metric_name=eps&utm_co

0 · Reply

M1LKY_0ctOPuSz Dec. 1 at 6:31 PM

$QDEL While giants spend billions perfecting logistics this platform benefits from every improvement for free and focuses only on UX, engagement and growth, that’s serious leverage

0 · Reply

Buckanator Nov. 28 at 3:56 PM

$QDEL Nice swing there for 25% profit so I’m out for now, I’ll be back

0 · Reply

Why One Value Fund Just Bought $30 Million of a Diagnostics Stock Down 90% From Pandemic-Era Highs

Dec 3, 2025, 3:43 PM EST - 10 days ago

QuidelOrtho Corporation (QDEL) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Nov 24, 2025, 7:00 AM EST - 19 days ago

QuidelOrtho To Participate In Upcoming Investor Conferences

Nov 20, 2025, 9:00 AM EST - 23 days ago

The Power of Prevention: Detecting Diabetes Before It Strikes

Nov 6, 2025, 5:46 AM EST - 5 weeks ago

QuidelOrtho Corporation (QDEL) Q3 2025 Earnings Call Transcript

Nov 5, 2025, 4:05 PM EST - 5 weeks ago

QuidelOrtho Reports Third Quarter 2025 Financial Results

Nov 3, 2025, 7:00 AM EST - 5 weeks ago

QuidelOrtho Receives FDA 510(k) Clearance for VITROS™ Immunodiagnostic Products hs Troponin I Assay

Oct 23, 2025, 6:45 PM EDT - 7 weeks ago

Informatics Illuminated: Science Bytes Podcast Explores the Power Behind Smarter Diagnostics

Oct 22, 2025, 7:00 AM EDT - 7 weeks ago

QuidelOrtho to Report Third Quarter 2025 Financial Results

Oct 16, 2025, 8:30 PM EDT - 2 months ago

QuidelOrtho Showcases Leadership in Transfusion Medicine at AABB 2025

Sep 25, 2025, 9:00 AM EDT - 2 months ago

Through Shades of Illness: Science Bytes Podcast Discusses Why Testing Matters

Sep 22, 2025, 7:00 AM EDT - 2 months ago

QuidelOrtho Announces Availability of QUICKVUE™ Influenza + SARS Test for Professional Use

Aug 28, 2025, 7:30 AM EDT - 3 months ago

QuidelOrtho to Participate in the Baird 2025 Global Healthcare Conference

Aug 21, 2025, 4:30 PM EDT - 4 months ago

QuidelOrtho Completes Debt Refinancing

Aug 21, 2025, 9:00 AM EDT - 4 months ago

Science Bytes Podcast Explores How Diagnostics Can Help Protect Students and Communities

Aug 19, 2025, 4:05 PM EDT - 4 months ago

QuidelOrtho Welcomes Erich Wolff as Executive Vice President, Strategy & Corporate Development

Aug 13, 2025, 3:00 PM EDT - 4 months ago

QuidelOrtho Launches Certified Analyzer Program

Aug 6, 2025, 1:07 AM EDT - 4 months ago

QuidelOrtho Corporation (QDEL) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 12:18 AM EDT - 4 months ago

QuidelOrtho (QDEL) Fiscal Q2 EPS Beats

Aug 5, 2025, 4:10 PM EDT - 4 months ago

QuidelOrtho Reports Second Quarter 2025 Financial Results

Jul 29, 2025, 5:00 PM EDT - 4 months ago

QuidelOrtho Recognized with Three Awards in 2025 IMV ServiceTrak™

Jul 24, 2025, 9:00 AM EDT - 5 months ago

Urgent Need for Early Detection in Drug Overdose Cases Highlighted in New Podcast

Jul 22, 2025, 4:30 PM EDT - 5 months ago

QuidelOrtho to Report Second Quarter 2025 Financial Results

Jul 17, 2025, 7:00 AM EDT - 5 months ago

Real Labs, Actual Decisions With Actionable Six Sigma Metrics

Jul 14, 2025, 7:00 AM EDT - 5 months ago

QUIDELORTHO AND BÜHLMANN LABORATORIES AG ANNOUNCE AVAILABILITY OF FECAL CALPROTECTIN (FCAL®) TURBO AND FECAL PANCREATIC ELASTASE (FPELA®) TURBO ASSAYS ON VITROS™ SYSTEMS AS A MICROTIP™ PARTNERSHIP ASSAY (MPA)

Jul 7, 2025, 7:00 AM EDT - 5 months ago

QuidelOrtho Strengthens Leadership Team With Appointments of Senior Vice Presidents for Global Quality and Clinical & Regulatory Affairs

Jun 3, 2025, 4:10 PM EDT - 6 months ago

QuidelOrtho Announces Strategy to Accelerate Growth in Molecular Diagnostics

May 22, 2025, 4:30 PM EDT - 7 months ago

QuidelOrtho to Participate in Upcoming Investor Conferences

May 12, 2025, 9:30 AM EDT - 7 months ago

QuidelOrtho: Stagnant Growth Means Best To Avoid (Rating Downgrade)

May 7, 2025, 7:56 PM EDT - 7 months ago

QuidelOrtho Corporation (QDEL) Q1 2025 Earnings Call Transcript

May 7, 2025, 4:05 PM EDT - 7 months ago

QuidelOrtho Reports First Quarter 2025 Financial Results

Apr 23, 2025, 4:30 PM EDT - 8 months ago

QuidelOrtho to Report First Quarter 2025 Financial Results

Mar 10, 2025, 9:00 AM EDT - 9 months ago

QuidelOrtho® Introduces Results Manager™ System

Feb 24, 2025, 7:00 AM EST - 10 months ago

QuidelOrtho to Participate in the 46th Annual Raymond James Institutional Investor Conference

Feb 13, 2025, 6:19 PM EST - 10 months ago

Why QuidelOrtho Stock Bounced More Than 4% Higher Today

Feb 12, 2025, 7:50 PM EST - 10 months ago

QuidelOrtho Corporation (QDEL) Q4 2024 Earnings Call Transcript

Feb 12, 2025, 4:05 PM EST - 10 months ago

QuidelOrtho Reports Fourth Quarter and Full-Year 2024 Financial Results

Jan 13, 2025, 9:00 AM EST - 11 months ago

QuidelOrtho Announces Preliminary Unaudited Revenue for Fourth Quarter 2024

Jan 7, 2025, 12:48 AM EST - 1 year ago

Kuehn Law Encourages Investors of QuidelOrtho Corporation to Contact Law Firm

Dec 31, 2024, 7:00 AM EST - 1 year ago

QuidelOrtho to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Dec 10, 2024, 7:00 AM EST - 1 year ago

QuidelOrtho Announces Appointment of Two Independent Directors to its Board

Nov 20, 2024, 3:08 PM EST - 1 year ago

Carlyle Sells QuidelOrtho Shares, Analyst Sees Overhang Lifted

Nov 20, 2024, 8:06 AM EST - 1 year ago

Powell Industries Reports Weak Sales, Joins Target, QuidelOrtho And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

TGT POWL

Nov 19, 2024, 9:05 PM EST - 1 year ago

QuidelOrtho Corporation Announces Pricing of Secondary Offering of Common Stock by the Carlyle Group

Nov 19, 2024, 4:54 PM EST - 1 year ago

QuidelOrtho Corporation Announces Secondary Offering of Common Stock by the Carlyle Group

Nov 11, 2024, 6:18 AM EST - 1 year ago

Top 4 Health Care Stocks That May Plunge This Quarter

AIRS NUVB PODD

Nov 8, 2024, 12:39 PM EST - 1 year ago

QuidelOrtho Surpasses Expectations in Q3

Nov 7, 2024, 8:54 PM EST - 1 year ago

QuidelOrtho Corporation (QDEL) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 4:05 PM EST - 1 year ago

QuidelOrtho Reports Third Quarter 2024 Financial Results

Money_Stream_6524 Dec. 12 at 5:14 PM

$QDEL Mainz Biomed is doing the boring work I respect, shifting away from expensive DTC and leaning into lab partners, and they reported lab partner sales up about $60K or ~30% over 6 months

0 · Reply

Staska Dec. 12 at 2:46 PM

0 · Reply

landonmorris13 Dec. 11 at 8:00 PM

$QDEL Mainz Biomed tape is so thin that a 20–30k order can reclaim VWAP around 1.07–1.08 and tag 1.10 in minutes, once 1.12 breaks I’m eyeing that 1.15–1.20 shelf as the next liquidity magnet

0 · Reply

goinbananas Dec. 11 at 6:58 PM

$QDEL I’ll take a nice 30% gain in 5 weeks any time 👍 lot more coming! $ARKG $LABU $QQQ

0 · Reply

Staska Dec. 11 at 6:45 PM

0 · Reply

Staska Dec. 11 at 5:20 PM

$QDEL https://www.marketbeat.com/instant-alerts/filing-norges-bank-invests-927-million-in-quidelortho-corporation-qdel-2025-12-10/

0 · Reply

AdamInvest Dec. 10 at 7:54 AM

$QDEL down down

0 · Reply

Estimize Dec. 3 at 1:09 PM

Wall St is expecting 0.42 EPS for $QDEL Q4 [Reporting 02/18 AMC] http://www.estimize.com/intro/qdel?chart=historical&metric_name=eps&utm_co

0 · Reply

M1LKY_0ctOPuSz Dec. 1 at 6:31 PM

$QDEL While giants spend billions perfecting logistics this platform benefits from every improvement for free and focuses only on UX, engagement and growth, that’s serious leverage

0 · Reply

Buckanator Nov. 28 at 3:56 PM

$QDEL Nice swing there for 25% profit so I’m out for now, I’ll be back

0 · Reply

Staska Nov. 26 at 10:23 PM

$QDEL https://www.marketbeat.com/instant-alerts/joseph-busky-acquires-4770-shares-of-quidelortho-nasdaqqdel-stock-2025-11-25/

0 · Reply

AdamInvest Nov. 26 at 9:54 PM

$QDEL

0 · Reply

Staska Nov. 25 at 8:24 PM

$QDEL Since 3Q report drop of 22% stock went up by almost 50% shorts must be happy now 🤣🤣

0 · Reply

Staska Nov. 25 at 8:21 PM

$QDEL Go QuidelOrtho! 🚀

0 · Reply

AdamInvest Nov. 21 at 4:50 PM

$QDEL if this pig hits $29 im all in on puts

0 · Reply

StockBraker Nov. 21 at 2:02 PM

$QDEL https://www.tipranks.com/news/insider-trading/ceo-makes-bold-move-with-major-stock-purchase-in-quidelortho-insider-trading

0 · Reply

Pharmer23 Nov. 21 at 1:36 PM

$QDEL time to get back into this after a few years . I see a double by next year . They’re closing up the shitty ortho business and getting lean . I’m in

0 · Reply

CEOBuysDisclosures Nov. 20 at 11:20 PM

$QDEL CEO purchased 23,500 shares at $21.34 for a total of $501,577. Blaser Brian J. now owns 40,984 shares. https://ceo-buys.com

0 · Reply

Estimize Nov. 20 at 9:00 PM

Wall St is expecting 0.42 EPS for $QDEL Q4 [Reporting 02/18 AMC] http://www.estimize.com/intro/qdel?chart=historical&metric_name=eps&utm_co

0 · Reply

Chickenstick1 Nov. 14 at 3:47 PM

$QDEL I'm a buyer right here. Someone fund is having their way with it... obviously.

0 · Reply

RunnerSignals Nov. 11 at 7:18 PM

Oversold Alert $NVO $EVH $SGRY $ODD $QDEL catching eyes today Some bouncing back, others still bleeding. Who is the real bargain vs falling knife? Read the full breakdown https://stocksrunner.com/news/2025-11-11-oversold-stocks-today-show-recovery-signals

0 · Reply

Chickenstick1 Nov. 10 at 7:11 PM

$QDEL The quarter wasnt "this" bad. I still like it for a trade back to $30.

0 · Reply

Market Cap	1.96B
Revenue (ttm)	2.78B
Net Income (ttm)	-2.05B
EPS (ttm)	N/A
PE Ratio	12.95
Forward PE	14.23
Profit Margin	-73.74%
Debt to Equity Ratio	1.31

Volume	603,300
Avg Vol	1,392,986
Day's Range	N/A - N/A
Shares Out	67.93M
Stochastic %K	61%
Beta	0.58
Analysts	Sell
Price Target	$37.67